About
Pressroom
Resources
Get Updates
Issues
Access to Medicines
Funding the Fight
Health Justice
Transparency & Accountability
PEPFAR Watch
Blog
Our Impact
Take Action
Do something now
DONATE
As Poor Nations Seek Covid Pills, Officials Fear Repeat of AIDS Crisis
A compromise on patent waivers for Covid-19 vaccines takes a key step at the WTO
Pfizer faces criticism for arguing that intellectual property for its Covid-19 pill is a human right
Covid Booster Costs Spur Calls to Shift From Free Jabs for All
Congressional delays could undermine COVID-19 global fight
How President Biden Can Expand Global COVID-19 Test-To-Treat
African clinical trial denied access to key COVID drug Paxlovid
Column: While we line up for a fourth shot, the world’s poor haven’t gotten their first
Rich countries are getting the new COVID vaccine first
Pfizer inks deal with UNICEF to supply Covid pill to poor countries, but advocates say it isn’t enough
A compromise is reached on an intellectual property waiver for Covid-19 vaccines, but does it go far enough?
Pfizer’s Paxlovid Goes Generic in 95 Countries – Too Little, Too Late, say Access Advocates
New “Compromise” on IP Waiver for Covid Vaccines Is Worse Than No Deal, Activists Say
Covid Pill Prescriber Rules Limit Reach of ‘Test to Treat’ Plan
Poor countries struggled to get covid vaccines. Now it’s happening with game-changing pills.
Ukraine-Russia War Threatens to Stymie Covid Vaccination Efforts
Four ways to beat the next pandemic
Pfizer criticized over patent strategy for Covid-19 pill, despite a deal to broaden access in poor countries
COVID inequity: In Africa, at-home tests are scarce, costly
Such a deal! Covid-19 therapies appear cost-effective…for now
SEE MORE